Monday, Apr 20, 2026 · SEC filings

What the smart money revealed on Apr 20

Real insider buys39insiders · $174M
Real insider sales37insiders · $43.5M
Fund 13Fs filed172quarterly holdings
Activist 13Ds filed05%+ stakes

268 insider filings came in. We hid 58 planned (10b5-1) sellers and 121 people whose filings were routine, like grants and tax withholding.

group

7 insiders at Arxis (ARXS) bought $5.64M of stock

Roles: Chief Accounting Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 17
$5.64M
group

4 insiders at Aevex (AVEX) bought $1.22M of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Apr 16
$1.22M
trending_up

Kailera Therapeutics (KLRA) Director Andrew Kaplan bought $134M

8.4M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 20
$134M
trending_up

Kailera Therapeutics (KLRA) Director Adam Koppel bought $25M

1.56M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 20
$25M
trending_up

Alamar Biosciences (ALMR) Director Nicholas Naclerio bought $4M

235,294 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 20
$4M
trending_up

Home Bancshares (HOMB) Chairman & CEO John Allison bought $2.7M

100,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Apr 17
$2.7M
account_balance

Lilly Endowment filed its holdings: 1 stocks

Holdings as of Mar 31, 2026. Open the fund to see what it bought and sold.

13F As of Mar 31
$84.5B
account_balance

Cardano Risk Management B.V. filed its holdings: 44 stocks

Holdings as of Mar 31, 2026. Open the fund to see what it bought and sold.

13F As of Mar 31
$10.2B
trending_down

ASE Technology Holding (ASX) Director Jeffrey Chen sold $12.3M

Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 119,000 shares.

Real sale Form 4 Traded Apr 16–20
$12.3M
trending_down

Argan (AGX) President and CEO David Watson sold $11.6M

Not marked as a planned 10b5-1 sale. Sold 28% of the shares they held directly. Still holds 49,998 shares.

Real sale Form 4 Sold 28% of stake Traded Apr 17
$11.6M
trending_down

Argan (AGX) CFO Joshua Baugher sold $363K

Not marked as a planned 10b5-1 sale. Sold 29% of the shares they held directly. Still holds 1,479 shares.

Real sale Form 4 Sold 29% of stake Traded Apr 16
$363K
Show 24 more real buys
OKTA Okta · Director David Schellhase · Traded Apr 16
$267K
SWZ Total Return Securities Fund · President and CEO Andrew Dakos · Traded Apr 16–17
$68.3K
KYN Kayne Anderson Energy Infrastructure Fund · Executive Vice President Harrison Little · Traded Apr 17
$66K
GLOO Gloo · President and CEO Scott Beck · Traded Apr 17–20
$51.8K
BIP Ventures Evergreen BDC · CEO Mark Buffington · Traded Apr 17
$50K
PALX Palomino Laboratories · Secretary Richard Ogawa · Traded Apr 20
$50K
XZO Exzeo Group · CEO Paresh Patel · Traded Apr 17
$33.9K
LOVE Lovesac · CEO Shawn Nelson · Traded Apr 16
$25K
PRHI Presurance · Director James Smith · Traded Apr 6–13
$18.4K
HUIZ Huize Holding · CEO Cunjun Ma · Traded Apr 16
$16.9K
CHCO City Holding · Director Robert Fisher · Traded Apr 20
$16.8K
BMNR Bitmine Immersion Technologies · Director Lori Love · Traded Apr 16–20
$15.4K
CHCO City Holding · Director Diane Strong-Treister · Traded Apr 20
$15K
CHCO City Holding · Director Javier Reyes · Traded Apr 20
$13K
CHCO City Holding · Director James Hoyer · Traded Apr 20
$13K
CGTX Cognition Therapeutics · CFO John Doyle · Traded Apr 16
$11.3K
CGTX Cognition Therapeutics · Chief Medical Officer Anthony Caggiano · Traded Apr 16
$11.1K
TIVC Tivic Health Systems · Director Sheryle Bolton · Traded Apr 15
$10.4K
CGTX Cognition Therapeutics · CEO & President Lisa Ricciardi · Traded Apr 16
$10.1K
AXIAY AXIA Energia S.A. · Director Matte Corso · Traded Apr 17
$6.03K
SVRN OceanPal · Co-CEO Salvatore Ternullo · Traded Apr 17
$5.17K
DLPN Dolphin Entertainment · CEO William O'Dowd · Traded Apr 20
$4.86K
FTLF Fitlife Brands · Director Seth Yakatan · Traded Jan 15
$2.52K
CIA Citizens · Director Cynthia Davis · Traded Mar 25
$453
Show 34 more real sales
ROIV Roivant Sciences · CEO Matthew Gline · Traded Apr 16
$8.45M
MS Morgan Stanley · Chief Legal/Admin Officer Eric Grossman · Traded Apr 20
$2.12M
JBL Jabil · EVP Steven Borges · Traded Apr 17
$1.63M
SRRK Scholar Rock Holding · CEO David Hallal · Traded Apr 16
$1.52M
PLAB Photronics · Director Kang Lee · Traded Apr 16
$918K
AEHR Aehr Test Systems · Director Rhea Posedel · Traded Apr 20
$661K
SRRK Scholar Rock Holding · President of R&D Akshay Vaishnaw · Traded Apr 16
$607K
SRRK Scholar Rock Holding · CFO Vikas Sinha · Traded Apr 16
$516K
SRRK Scholar Rock Holding · COO Keith Woods · Traded Apr 16
$507K
JBL Jabil · SVP May Yap · Traded Apr 16
$501K
ITUB Itau Unibanco Holding S.A. · Chief People and MKT Officer Fajerman Guillinet · Traded Apr 17
$376K
AMKR Amkor Technology · EVP & General Counsel Mark Rogers · Traded Apr 16
$297K
AEHR Aehr Test Systems · Exec VP of Sales & Mktg. Vernon Rogers · Traded Apr 20
$219K
KALV KalVista Pharmaceuticals · CEO Benjamin Palleiko · Traded Apr 17
$193K
LIF Life360 · CEO Lauren Antonoff · Traded Apr 16
$123K
UNTY Unity Bancorp · Director Mary Gross · Traded Apr 17
$116K
NRDY Nerdy · Chief Legal Officer Christopher Swenson · Traded Apr 16
$64.9K
KALV KalVista Pharmaceuticals · Chief Medical Officer Paul Audhya · Traded Apr 17
$54.3K
AFYA Afya · Controller Santos Ferreira · Traded Apr 17
$52.9K
ATLX Atlas Lithium · CFO Tiago Miranda · Traded Apr 16–17
$51.3K
OFIX Orthofix Medical · CLO Jorge Cedron · Traded Apr 16
$48K
WABC Westamerica Bancorporation · SVP/Banking Division Manager Robert Baker · Traded Apr 20
$40.9K
KALV KalVista Pharmaceuticals · Chief Commercial Officer Nicole Sweeny · Traded Apr 17
$37.6K
KALV KalVista Pharmaceuticals · CFO Brian Piekos · Traded Apr 17
$37.6K
NRDY Nerdy · COO John Paszterko · Traded Apr 16
$29.6K
ESEA Euroseas · Corporate Secretary Stefania Karmiri · Traded Apr 16
$18K
VLN Valens Semiconductor · Director Tal Yaacobi · Traded Apr 16
$5.51K
VLN Valens Semiconductor · Director Moshe Lichtman · Traded Apr 16
$5.51K
NA Nano Labs · Director Nan Hu · Traded Apr 17
$4.66K
CRGO Freightos · CTO Abril Alventosa · Traded Apr 16
$4.66K
CRGO Freightos · Chief Strategy Officer Ian Arroyo · Traded Apr 16
$3.24K
DNA Ginkgo Bioworks · Officer Steven Coen · Traded Apr 17
$2.58K
CRGO Freightos · VP Sesma Indave · Traded Apr 16
$1.57K
GAB.RT Gabelli Equity Trust · Director Eileen Nakamura · Traded Apr 16
$771

13F season

Holdings as of Mar 31, 2026 are due May 15

8,903 funds have filed so far. 315 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Apr 20.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist